Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist

Behavioural Brain Research

Volumn 73, Issue 1-2, 1995, Pages 163-167

  Moser, P C ^a   Moran, P M ^a   Frank, R A ^b   Kehne, J H ^c  

^a SANOFI   (France)

^b UNIVERSITY OF CINCINNATI   (United States)

^c Merrell Dow Research Institute   (United States)

Author keywords

5 HT2A receptor antagonist; Amphetamine; Drug discrimination; Latent inhibition; MDL 100,907; Schizophrenia; Self stimulation

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; AMPHETAMINE; CLOZAPINE; HALOPERIDOL; RITANSERIN; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; SCHIZOPHRENIA; SELF STIMULATION;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DISCRIMINATION (PSYCHOLOGY); FLUOROBENZENES; MALE; MOTOR ACTIVITY; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SELF STIMULATION; SEROTONIN ANTAGONISTS; STARTLE REACTION;

EID: 0030064086     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00090-3     Document Type: Article

References (21)

1. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia
2. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin pKi values
3. 3 mediated control of dopaminergic function
4. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioural, electrophysiological and neurochemical studies
5. 2A antagonist, MDL 100,907 increases dopamine efflux in the prefrontal cortex of the rat
6. 3 receptor antagonists on the discriminative stimulus effects of amphetamine
7. 3 antagonist, facilitates latent inhibition in the rat
8. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
9. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder
10. Animal models with construct validity for schizophrenia
11. The neuropsychology of schizophrenia
12. Latent inhibition and schizophrenia
13. Differential performance of acute and chronic schizophrenics in a latent inhibition task
14. Latent inhibition of conditioned dopamine release in rat nucleus accumbens
15. Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus
16. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethampetamine
17. Cuing effect of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens
18. 6-Hydroxydopamine lesions of the nucleus accumbens attenuate the discriminative stimulus effects of d-amphetamine
19. Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental area
20. D-amphetamine-like stimulus properties are produced by morphine injections into the ventral tegmental area but not into the nucleus accumbens